The cardio-oncologic burden of breast cancer: molecular mechanisms and importance of preclinical models DOI Creative Commons
Jürgen Bräuer,

M. Tumani,

Norbert Frey

et al.

Basic Research in Cardiology, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 2, 2024

Abstract Breast cancer, the most prevalent cancer affecting women worldwide, poses a significant cardio-oncological burden. Despite advancements in novel therapeutic strategies, anthracyclines, HER2 antagonists, and radiation remain cornerstones of oncological treatment. However, each carries risk cardiotoxicity, though molecular mechanisms underlying these adverse effects differ. Common include DNA damage response, increased reactive oxygen species, mitochondrial dysfunction, which are key areas ongoing research for potential cardioprotective strategies. Since also essential effective tumor cytotoxicity, we explore tumor-specific effects, particularly hereditary breast linked to BRCA1 BRCA2 mutations. These genetic variants impair repair mechanisms, increase tumorigenesis possibly cardiotoxicity from treatments such as anthracyclines antagonists. Novel therapies, including immune checkpoint inhibitors, used clinic triple-negative improve outcomes patients. This review discusses BRCA dysfunction associated pathological pathways. It gives an overview preclinical models genetically engineered mouse models, syngeneic murine humanized various vitro ex vivo systems study cardiovascular side therapies. Understanding mechanism developing strategies improving treatment reducing long-term risks

Language: Английский

Prospective Cohort Study of Trastuzumab Biosimilar CT-P6 in HER2-Positive Gastric Cancer: Japanese Real-World Outcomes DOI Creative Commons
Hiroya Taniguchi, Kiyohiro Nishikawa,

Tatsuji Haneji

et al.

Oncology and Therapy, Journal Year: 2025, Volume and Issue: unknown

Published: May 8, 2025

CT-P6, the first trastuzumab biosimilar, was approved on basis of data limited to human epidermal growth factor receptor-2 (HER2)-positive early breast cancer. Usage for other indications granted by extrapolation, and post-approval clinical studies were conducted confirm effect CT-P6 in HER2-positive gastric After approval Japan 2018, a prospective post-marketing surveillance 171 patients (130 male, 41 female) with unresectable advanced or recurrent The safety efficacy evaluated over 1 year. primarily combined fluoropyrimidine and/or platinum agents. Adverse events occurred 151 (88.3%), 55 (32.2%) experiencing grade 3 higher. Infusion reactions 12.3%. Four cardiac disorders reported: two dysfunction severe ischemic heart disease. Interstitial lung disease reported four (2.3%). objective response rate 34.4%, control 82.4%. progression-free survival (PFS) 7.4 months. Significant risk factors PFS included gastroesophageal junction, ≥ metastases, no gastrectomy, prior chemotherapy, agent. In this cohort study, demonstrated sufficient new concerns cancer, serving as cost-effective alternative originator trastuzumab. Registry Clinical Trials, Trial ID: jRCT2071230094 (November 2023).

Language: Английский

Citations

0

Metabolic Reprogramming in Cancer Therapy-Related Cardiovascular Toxicity: Mechanisms and Intervention Strategies DOI
Cheng Zeng, Ying Gao, Bo Lan

et al.

Seminars in Cancer Biology, Journal Year: 2025, Volume and Issue: unknown

Published: May 1, 2025

Language: Английский

Citations

0

Vagus nerve stimulation and acetylcholinesterase inhibitor donepezil provide cardioprotection against trastuzumab-induced cardiotoxicity in rats by attenuating mitochondrial dysfunction DOI
Thawatchai Khuanjing, Chayodom Maneechote, Benjamin Ongnok

et al.

Biochemical Pharmacology, Journal Year: 2023, Volume and Issue: 217, P. 115836 - 115836

Published: Oct. 9, 2023

Language: Английский

Citations

9

Curcumin pretreatment attenuates myocardial ischemia/reperfusion injury by inhibiting ferroptosis, autophagy and apoptosis via HES1 DOI

Yong Yuan,

Huang Huang, Tie Hu

et al.

International Journal of Molecular Medicine, Journal Year: 2024, Volume and Issue: 54(6)

Published: Oct. 1, 2024

The early restoration of hemodynamics/reperfusion in acute myocardial infarction (AMI) is an effective therapeutic strategy to reduce sudden death and improve patient prognosis. However, reperfusion induces additional cardiomyocyte damage cardiac tissue dysfunction. In this context, turmeric‑derived curcumin (Cur) has been shown exhibit a protective effect against ischemia/reperfusion injury (I/RI). molecular mechanism its activity, however, remains unclear. current study investigated the Cur via

Language: Английский

Citations

3

Swimming training attenuates doxorubicin induced cardiomyopathy by targeting the mir-17-3p/KEAP1/NRF2 axis DOI

Yefei Gao,

Ling Yan,

Haowei Wu

et al.

Biochemical and Biophysical Research Communications, Journal Year: 2024, Volume and Issue: 739, P. 150568 - 150568

Published: Aug. 19, 2024

Language: Английский

Citations

2

Ferroptosis and Its Potential Role in the Physiopathology of Skeletal Muscle Atrophy DOI Open Access

Chen‐Chen Sun,

Jiang-Ling Xiao,

Chen Sun

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(22), P. 12463 - 12463

Published: Nov. 20, 2024

Skeletal muscle atrophy is a major health concern, severely affecting the patient's mobility and life quality. In pathological process of skeletal atrophy, with progressive decline in quality, strength, function, incidence falling, fracture, death greatly increased. Unfortunately, there are no effective treatments for this devastating disease. Thus, it imperative to investigate exact molecular mechanisms underlying development identify new therapeutic targets. Decreased mass, fiber cross-sectional area typical features manifestations atrophy. Ferroptosis, an emerging type programmed cell death, characterized by iron-dependent oxidative damage, lipid peroxidation, reactive oxygen species accumulation. Notably, understanding its role emerging. Ferroptosis has been found play important intricate interplay between progression caused multiple factors. This provides opportunities challenges treatment Therefore, we systematically elucidated ferroptosis mechanism progress aiming provide comprehensive insight into relationship from perspectives iron metabolism peroxidation insights targeting pathways related

Language: Английский

Citations

2

Ferroptosis, a therapeutic target for cardiovascular diseases, neurodegenerative diseases and cancer DOI Creative Commons
Yinghui Li, Cui-Yun Liu, Bo Fang

et al.

Journal of Translational Medicine, Journal Year: 2024, Volume and Issue: 22(1)

Published: Dec. 22, 2024

The identification of ferroptosis represents a pivotal advancement in the field cell death research, revealing an entirely novel mechanism cellular demise and offering new insights into initiation, progression, therapeutic management various diseases. Ferroptosis is predominantly induced by intracellular iron accumulation, lipid peroxidation, or impairments antioxidant defense system, culminating membrane rupture consequent death. Studies have associated with wide range diseases, enhancing our comprehension its underlying mechanisms, we can formulate innovative strategies, thereby providing renewed hope for patients.

Language: Английский

Citations

2

The mechanism of 14-3-3η in thyroxine induced mitophagy in cardiomyocytes DOI

Yalan Cui,

Yan Zhang,

Songsong Dai

et al.

Molecular and Cellular Endocrinology, Journal Year: 2024, Volume and Issue: 590, P. 112271 - 112271

Published: May 15, 2024

Language: Английский

Citations

2

The Therapeutic Potential of Targeting Ferroptosis in the Treatment of Mitochondrial Cardiomyopathies and Heart Failure DOI
Aubrey C. Cantrell,

Heng Zeng,

Jian‐Xiong Chen

et al.

Journal of Cardiovascular Pharmacology, Journal Year: 2023, Volume and Issue: unknown

Published: Oct. 10, 2023

Ferroptosis is a form of iron-regulated cell death implicated in wide array diseases, including heart failure, hypertension, and numerous cardiomyopathies. In addition, mitochondrial dysfunction has been associated with several these same disease states. However, the role mitochondrion ferroptotic remains debated. As major regulator cellular iron levels, mitochondria may very well play crucial mechanisms behind ferroptosis, but at this point, not adequately defined. Emerging evidence from our laboratory others indicates critical Sirtuin 3, deacetylase linked longevity protection against conditions, prevention cardiovascular diseases. Here, we provide brief overview potential roles 3 homeostasis its contribution to cardiomyopathy Friedreich's ataxia diabetic cardiomyopathy. We also discuss current knowledge involvement ferroptosis other states, doxorubicin-induced cardiomyopathy, insight into areas requiring further investigation.

Language: Английский

Citations

5

The association between ferroptosis and autophagy in cardiovascular diseases DOI
Yifan Zhang, Junjun Yang, Chenxi Ouyang

et al.

Cell Biochemistry and Function, Journal Year: 2024, Volume and Issue: 42(2)

Published: March 1, 2024

Abstract Autophagy is a process in which cells degrade intracellular substances and play variety of roles cells, such as maintaining homeostasis, preventing cell overgrowth, removing pathogens. It highly conserved during the evolution eukaryotic cells. So far, study autophagy still hot topic field cytology. Ferroptosis an iron‐dependent form death, accompanied by accumulation reactive oxygen species lipid peroxides. With deepening research, it has been found that ferroptosis, like autophagy, involved occurrence development cardiovascular diseases. The relationship between ferroptosis complex, association two disease remains to be clarified. This article reviews mechanism their correlation, discusses them diseases, expected provide new important treatment strategies for

Language: Английский

Citations

1